Key Market Indicators
Slovene hormone sales are expected to reach $16 million by 2026. Last year, the country's market was valued at $15 million, showing an average year-on-year growth of 1.4%. Since 2012, Slovene market growth has jumped by 4.4%. In 2021, Slovenia ranked 24th in the world, with New Zealand overtaking with $15 million in sales. Germany, the United Kingdom and Italy followed in second, third and fourth place respectively.